224 related articles for article (PubMed ID: 35890347)
21. Defining the epitope of a blood-brain barrier crossing single domain antibody specific for the type 1 insulin-like growth factor receptor.
Sheff J; Wang P; Xu P; Arbour M; Masson L; van Faassen H; Hussack G; Kemmerich K; Brunette E; Stanimirovic D; Hill JJ; Kelly J; Ni F
Sci Rep; 2021 Feb; 11(1):4284. PubMed ID: 33608571
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26.
Thom G; Burrell M; Haqqani AS; Yogi A; Lessard E; Brunette E; Delaney C; Baumann E; Callaghan D; Rodrigo N; Webster CI; Stanimirovic DB
Mol Pharm; 2018 Apr; 15(4):1420-1431. PubMed ID: 29485883
[TBL] [Abstract][Full Text] [Related]
23. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
[TBL] [Abstract][Full Text] [Related]
24. Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeability.
Sakamoto K
Biochem Biophys Rep; 2022 Dec; 32():101367. PubMed ID: 36237444
[TBL] [Abstract][Full Text] [Related]
25. Use of LDL receptor-targeting peptide vectors for
Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
[TBL] [Abstract][Full Text] [Related]
26. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
[TBL] [Abstract][Full Text] [Related]
27. A novel LRP1-binding peptide L57 that crosses the blood brain barrier.
Sakamoto K; Shinohara T; Adachi Y; Asami T; Ohtaki T
Biochem Biophys Rep; 2017 Dec; 12():135-139. PubMed ID: 29090274
[TBL] [Abstract][Full Text] [Related]
28. Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain.
Christensen SC; Krogh BO; Jensen A; Andersen CBF; Christensen S; Nielsen MS
Sci Rep; 2020 Sep; 10(1):14582. PubMed ID: 32884039
[TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated therapeutic transport across the blood-brain barrier.
Wang YY; Lui PC; Li JY
Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
[TBL] [Abstract][Full Text] [Related]
30. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport.
Fang F; Zou D; Wang W; Yin Y; Yin T; Hao S; Wang B; Wang G; Wang Y
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1316-1327. PubMed ID: 28482500
[TBL] [Abstract][Full Text] [Related]
32. Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
Cavaco M; Gaspar D; Arb Castanho M; Neves V
Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31940974
[TBL] [Abstract][Full Text] [Related]
33. Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges.
Pulgar VM
Front Neurosci; 2018; 12():1019. PubMed ID: 30686985
[TBL] [Abstract][Full Text] [Related]
34. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
35. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.
Ruiz-López E; Schuhmacher AJ
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439797
[TBL] [Abstract][Full Text] [Related]
36. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
[TBL] [Abstract][Full Text] [Related]
37. Targeting Malignant Brain Tumors with Antibodies.
Razpotnik R; Novak N; Čurin Šerbec V; Rajcevic U
Front Immunol; 2017; 8():1181. PubMed ID: 28993773
[TBL] [Abstract][Full Text] [Related]
38. Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.
Kim SY; Choi ES; Lee HJ; Moon C; Kim E
Colloids Surf B Biointerfaces; 2015 Dec; 136():989-96. PubMed ID: 26562191
[TBL] [Abstract][Full Text] [Related]
39. Enhanced
Esparza TJ; Su S; Francescutti CM; Rodionova E; Kim JH; Brody DL
bioRxiv; 2023 Apr; ():. PubMed ID: 37333358
[TBL] [Abstract][Full Text] [Related]
40. Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.
Pardridge WM
Expert Opin Drug Deliv; 2015 Feb; 12(2):207-22. PubMed ID: 25138991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
